Q. You recently wrote that testosterone does not increase the risks for heart attacks. But you overlooked the real risk of testosterone therapy: cancer!

There are four main causes of ED: psychogenic, vascular, hormonal and neurologic.

Black Californians are five times more likely than others to die of prostate cancer. Gov. Gavin Newsom vetoed a bill that would have cut screening costs.

Black men face the highest rate of prostate cancer diagnosis and death, with many being diagnosed at later stages due to a lack of awareness and access to screening, highlighting the need for more ...

The recommendation to introduce the use of chemical castration in restraining and curtailing convicted repeat rapists, is coming under the microscope for its ethical, medical and financial impact om ...

An individual-patient meta-analysis sheds light on the optimal duration of androgen deprivation therapy in men with prostate cancer on definitive radiotherapy.

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

A national clinical trial led by the Alliance for Clinical Trials in Oncology has found that oxybutynin, a drug often used to ...

Addition of 6 months of androgen deprivation therapy to stereotactic body radiotherapy more than doubled PFS in hormone-sensitive oligorecurrent prostate cancer. Nearly all patients treated with the ...

Metastasis-directed therapy (MDT) delivered via stereotactic body radiotherapy has gained substantial attention over the past decade. Landmark trials such as STOMP1 and ORIOLE2 fundamentally shifted ...

Health-related quality of life (HRQoL) outcomes with darolutamide in the phase 3 ARANOTE trial. A multicenter, randomized, phase 2, investigator-initiated ETCTN trial of olaparib + radium-223 vs.

SGLT2 inhibitor use was associated with a significantly lower risk for androgen deprivation therapy (ADT) failure and next-generation hormonal agent failure in men with prostate cancer. SGLT2 ...